openPR Logo
Press release

Facial Injectable Market Expanding at a Stable CAGR of 13.2% from 2016 to 2021

09-01-2017 01:55 PM CET | Health & Medicine

Press release from: Market Research Future

Market Scenario:
Facial Injectable or also known as dermal fillers are products which help in a trending application known as bio-engineering or facial rejuvenation. As humans age the facial skin is bound to lose subcutaneous fat naturally, the skin is lured closer to the facial working muscles hence smile lines and wrinkles over the face become more visible. The global market for facial injectable is expected to reach USD 9.04 billion by the end of the forecasted period and is expected to grow at a CAGR of 13.2%

Key Players for Facial Injectable Market:
• Allergan,
• Galderma,
• Integra Lifesciences,
• Merz Pharma,
• Sanofi,
• SciVision Biotech Inc,
• Sinclair.
• Suneva Medical
• Valeant Pharmaceuticals.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/1527

Key Findings
• The facial Injectable global market and is expected to reach USD9.04 billion by 2021.
• Botulinum Toxin holds the largest share of the market.
• North America holds the largest market share of facial injectable market and is anticipated to reach USD 3.42 billion by the end of forecast period.
• Globally, Asia-Pacific the fastest growing region and expected to grow at the CAGR of 13.6% during the forecast period.

Taste the market data and market information presented through more than 50 market data tables and figures spread in 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Global Facial Injectable Market Research Report- Forecast to 2021”

Regional Analysis of Facial Injectable Market:
Globally North America is the largest market for Facial Injectable. The North American market for facial injectable is expected to grow and is expected to reach at USD 3.42 billion by the end of the forecasted period. This is due to increasing approvals of facial inject-able products in emerging markets. Europe is the second-largest market for facial injectables. Whereas Asia pacific is expected to be a growing market for facial injectable and expected to grow at a rapid rate.

Access Report Details @ https://www.marketresearchfuture.com/reports/facial-injectable-market

Table of Content
1 market Overview
1.1 Product Overview and Scope of Facial Injectable
1.2 Specifications of Facial Injectable
1.2.1 Hyaluronic Acid
1.2.2 Collagen
1.2.3 Botulinum Toxin
1.2.4 Polymers and Particles
2 Research Methodolgy
2.1 Primary Research:
2.2 Secondary Research:
3 Market dynamics
3.1 Drivers
3.1.1 Growing demand for facial aesthetic treatments
3.1.2 Technological advancements
3.1.3 Effects of pollution
3.1.4 Increasing acceptance of soft tissue fillers
3.1.5 Growing demand for dermal filler techniques from Asian region
3.2 Restraints:
3.2.1 Complication during surgery
3.2.2 Side effects associated with facial injectable
3.3 Opportunity
3.3.1 Rising awareness about combination therapies
3.4 Porters Five Forces
3.5 Bargaining power of suppliers
3.6 BARGAINING POWER OF BUYERS
3.7 THREAT OF NEW ENTRANTS
3.8 Threat of Substitutes
3.9 Intensity of Rivalry
3.10 Value Chain Analysis
3.10.1 Inputs
3.10.2 Drug Development
3.10.3 Manufacturing process of facial injectable
3.10.4 Marketing and distribution
3.11 Supply Chain
4 global Facial Injectable Market by Regions
Continue…….
List of Tables
Table 1 Applications Of Facial Injectable 12
Table 2 Global Facial Injectable Market: Market Structure 16
Table 4 Global Facial Injectable Market Share, By Region 2015 (%) 27
Table 5 Global Facial Injectable Market Share, 2013-2021 (%) 28
Table 6 Global Facial Injectable Market: Import Export Data 2015 (Tons) 28
Table 7 North America Facial Injectable Market, By Country (Usd Million) 29
Table 8 North America Facial Injectable Market, By Country (Volume) 30
Continue……..

List Of Figures
Figure 1 Picture Of Facial Injectable Application 15
Figure 2 Research Process 17
Figure 3 Porters Five Forces Model 22
Figure 4 North America Facial Injectable Market, By Country (Usd Million) 29
Figure 5 North America Facial Injectable Market Share, By Type, 2015 (%) 30
Figure 6 North America Facial Injectable Market Share, By Application 2015 (%) 32
Figure 7 Us Facial Injectable Market Share, By Types, 2015 (%) 40
Figure 8 Us Facial Injectable Market Share, By Application 2015 (%) 41
Continue………..

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Facial Injectable Market Expanding at a Stable CAGR of 13.2% from 2016 to 2021 here

News-ID: 695232 • Views:

More Releases from Market Research Future

Global Neuroendoscopy Market to Surpass USD 1297.9 Billion by 2035 as AI-Guided Navigation and Minimally Invasive Techniques Redefine Neurosurgery
Global Neuroendoscopy Market to Surpass USD 1297.9 Billion by 2035 as AI-Guided …
The global Neuroendoscopy Market is entering a high-growth phase, fueled by a surge in brain tumor cases and the rapid integration of robotics and artificial intelligence into surgical workflows. According to the latest 2026 industry intelligence, the market is valued at approximately USD 444.04 million and is projected to reach USD 1,297.90 million by 2035, expanding at a robust compound annual growth rate (CAGR) of 11.39%. Neuroendoscopy has emerged as a
Global Stem Cell Assay Market Set to Reach USD 10.27 Billion by 2035 as Regenerative Medicine and Drug Discovery Enter New Era
Global Stem Cell Assay Market Set to Reach USD 10.27 Billion by 2035 as Regenera …
The global Stem Cell Assay Market is experiencing a period of exponential growth, fueled by the rapid expansion of regenerative medicine and a surging demand for physiologically relevant models in drug toxicity testing. According to recent industry analysis for 2026, the market is valued at approximately USD 5.04 billion and is projected to reach USD 10.27 billion by 2035, exhibiting a robust compound annual growth rate (CAGR) of 8.22%. As pharmaceutical
Global Healthcare IT Market Projected to Surpass USD 1,650.34 billion by 2035, Catalyzed by Generative AI and Cloud-Native Ecosystems
Global Healthcare IT Market Projected to Surpass USD 1,650.34 billion by 2035, C …
The global Healthcare IT Market is entering a new era of hyper-growth, driven by the mass adoption of generative AI, the decentralization of patient care, and a critical industry-wide push for data interoperability. According to the latest market intelligence, the sector is valued at approximately USD 386.58 billion in 2026 and is forecasted to accelerate at a remarkable compound annual growth rate (CAGR) of 17.5%, reaching USD 1,650.34 billion by
Global Medical Foods Market Poised to Reach USD 40.77 Billion by 2035, Driven by Personalized Nutrition and Chronic Disease Management
Global Medical Foods Market Poised to Reach USD 40.77 Billion by 2035, Driven by …
The global Medical Foods Market is undergoing a significant transformation, fueled by a paradigm shift in healthcare toward specialized, condition-specific nutritional interventions. According to the latest industry analysis, the market was valued at approximately USD 24.04 billion in 2024 and is projected to expand at a steady compound annual growth rate (CAGR) of 4.92%, reaching a staggering USD 40.77 billion by 2035. Medical foods, which are specifically formulated for the dietary

All 5 Releases


More Releases for Injectable

Key Small Molecule Injectable Drugs Market Trend for 2025-2034: Small Molecule I …
What Is the Future Outlook for the Small Molecule Injectable Drugs Market's Size and Growth Rate? The small molecule injectable drugs market has grown rapidly in recent years. It will rise from $219.57 billion in 2024 to $248.2 billion in 2025, at a CAGR of 13.0%. The growth is attributed to the rising prevalence of chronic diseases, an aging population, government initiatives, increased healthcare spending, and improvements in manufacturing processes. The small
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Facial Injectable Market Size to Hit $7.5 Billion by 2028 | Facial Injectable In …
According to our experience research team, Facial Injectable Market was valued at USD 4.4 Billion in 2021, and the global Facial Injectable industry is projected to reach a value of USD 7.5 Billion by 2028, at a CAGR of 9.4% during the forecast period 2022-2028 The report is focused on gaining various Facial Injectable market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global
Small-Molecule Injectable Market
The global Small-Molecule Injectable Market was valued at US$ 55.8 Bn in 2020. Expanding at a 7.3% CAGR, the market valuation is expected to top US$ 112.9 Bn by 2031, finds ESOMAR-certified consulting firm Future Market Insights (FMI) in a recent market analysis. The COVID-19 pandemic outbreak has sparked efforts to repurpose already-approved medicines for treatment. Several clinical studies are now being conducted on different antiviral medicines and small-molecule injectables that
Global Injectable Drug Delivery Devices Market | Global Injectable Drug Delivery …
The injectable drug delivery devices market involves of sales of conventional syringes, needle-free injectors, auto injectors and pen injectors. The market contains the sales of the Injectable devices that have been comprehensively utilized for several routes of drug administration, such as intravenous, subcutaneous, intradermal, intra-peritoneal, and intra-muscular and several others to cure the medical conditions vacillating from cancer to autoimmune disorders. The injectable drug delivery devices utilized in hospitals, clinics
Ioversol Market Report 2018: Segmentation by Type (Ioversol 34% Injectable Solut …
Global Ioversol market research report provides company profile for China Resources Pharmaceutical (Shanghai) Co, HB Ocean, Novalek Pharmaceuticals Pvt. Ltd, Stellence Pharmscience Pvt. Ltd, A.S. Joshi & Company, Liebel-Flarsheim Company LLC, Guerbet, Jiangsu Hengrui Medicine Co, Mallinckrodt Pharmaceuticals, Ultraject and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of